國家衛生研究院 NHRI:Item 3990099045/16863
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12500/13673 (91%)
Visitors : 2633136      Online Users : 717
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/16863


    Title: CAPE combined with Cisplatin or Docetaxel inhibits the survival and proliferation of non-small cell lung cancer cells
    Authors: Fu, YK;Kuo, LK;Chuu, CP
    Contributors: Institute of Cellular and Systems Medicine
    Abstract: The incidence and mortality rate of lung cancer is the highest cancer in the globally, whether in Europe, America or Asia. Lung cancer is mainly divided into two categories about small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), NSCLC is the most common, accounting for about 80% to 85%. Cisplatin and Docetaxel are currently the most commonly used chemotherapy drugs. Even though they are effective, they have serious side effects. Caffeic acid phenylethyl ester (CAPE) is the main component in poplar type propolis. We therefore explored if combined treatment of CAPE with Cisplatin or Docetaxel exhibits greater suprressive effects on survival of NSCLC cells. We observed that the combination of CAPE with Cisplatin or Docetaxel more effectively inhibited the cell proliferation and survival of H1299 and A549 cells than Cisplatin or Docetaxel alone and also more significantly suppressed expression of proteins involved in apoptosis, survival and cell cycle procession protein expression. Our observation suggested that combining CAPE with Cisplatin or Docetaxel can be a more effective treatment for NSCLC and may reduce undesired side effects.
    Date: 2024-03
    Relation: Cancer Science. 2024 Mar;115(Suppl. 1):959.
    Link to: https://onlinelibrary.wiley.com/toc/13497006/2024/115/S1
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001390207202110
    Appears in Collections:[Chih-Pin Chuu] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    ISI001390207202110.pdf505KbAdobe PDF15View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback